<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2014-05-14 13:42:40Biomarkers Biotechnology Chemical pathology Medical emergencies Cardiovascular disease Myocardial infarction Non-communicable disease Hypertension Rheumatoid arthritis Medicine Health Biology |
| Biotechnology, BS "DBEFNJD.BQ 5IF"DBEFNJD.BQTFSWFTBTBTVHHFTUFEDPVSTFTFRVFODFPOMZ4UVEFOUTBSFOPUMJNJUFEUPUIJTQMBO JUJTNFBOUUPCFVTFEBTDocID: 1xTqy - View Document |
| PDF DocumentDocID: 1wroO - View Document |
| Building A Better Mousetrap: Patenting Biotechnology In The European CommunityDocID: 1vr7C - View Document |
| BIOTECH & PHARMA IN FRANCE KEY FACTS & FIGURES ¾¾ The French biotechnology sector ranks number 3 in Europe with more than 400 companies behind the UK and Germany ¾¾ First producer of medicines in Europe with 220 prodDocID: 1vq6b - View Document |
| Biotechnology Consultation Agency Response Letter BNFDocID: 1vpUZ - View Document |